Zevra Therapeutics Inc ZVRA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
4.98quote price arrow up+0.25 (+5.29%)
Volume
4,137,384
Close
4.73quote price arrow down-0.03 (-0.63%)
Volume
143,551
52 week range
3.89 - 7.28
Loading...
  • Open4.75
  • Day High4.84
  • Day Low4.67
  • Prev Close4.76
  • 52 Week High7.28
  • 52 Week High Date02/20/24
  • 52 Week Low3.89
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap197.967M
  • Shares Out41.85M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.97
  • YTD % Change-27.79

KEY STATS

  • Open4.75
  • Day High4.84
  • Day Low4.67
  • Prev Close4.76
  • 52 Week High7.28
  • 52 Week High Date02/20/24
  • 52 Week Low3.89
  • 52 Week Low Date11/13/23
  • Market Cap197.967M
  • Shares Out41.85M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.97
  • YTD % Change-27.79

RATIOS/PROFITABILITY

  • EPS (TTM)-1.34
  • P/E (TTM)-3.52
  • Fwd P/E (NTM)-3.13
  • EBITDA (TTM)-54.238M
  • ROE (TTM)-84.68%
  • Revenue (TTM)28.007M
  • Gross Margin (TTM)51.11%
  • Net Margin (TTM)-181.75%
  • Debt To Equity (MRQ)97.20%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Zevra Therapeutics Inc

 

Profile

MORE
Zevra Therapeutics, Inc. is a rare disease company science, data, and patients need to create transformational therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical stage pipeline and commercial stage assets. Its pipeline includes arimoclomol, an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC)....
Tamara Favorito
Independent Chairman of the Board
Neil Mcfarlane
President, Chief Executive Officer, Director
R. LaDuane Clifton CPA
Chief Financial Officer, Treasurer, Secretary
Joshua Schafer
Executive Vice President - Business Development, Chief Commercial Officer
Address
1180 CELEBRATION BOULEVARD, SUITE 103
Celebration, FL
34747
United States

Top Peers

SYMBOLLASTCHG%CHG
BLUE
bluebird bio Inc
1.03-0.02-1.90%
CAPR
Capricor Therapeutics Inc
6.20+0.56+9.93%
FHTX
Foghorn Therapeutics Inc.
5.51-0.30-5.16%
HOWL
Werewolf Therapeutics Inc
4.72-0.16-3.28%
MGNX
MacroGenics Inc
4.37-0.75-14.75%